Chemiluminescence Platform

A diagnostic platform featuring high sensitivity and wide detection menu that comprehensively covers critical care, cardiovascular and cerebrovascular diseases, and other key clinical areas. The platform is widely applied in clinical departments such as laboratory medicine, emergency medicine, and ICU, while also suitable for diverse scenarios including primary healthcare facilities, health examination centers, and reproductive centers.

A comprehensive technology platform utilizing chemiluminescence immunoassay methodology for in vitro diagnostic testing. The platform enables sensitive and specific detection of various clinical markers including reproductive, autoimmune, infectious disease, and metabolic parameters.

A proprietary dry-phase photoactivated chemiluminescence technology platform for point-of-care testing. Covers cardiovascular, inflammatory, tumor marker, hormone, and infectious disease diagnostics.

A microarray-based chemiluminescence immunoassay platform using hard-substrate glass slides as carriers with covalently bound monoclonal antibodies. The platform features integrated positive and negative quality control points, multi-parameter detection with up to 56 array points, and a sandwich immunoassay methodology. It combines high-sensitivity chemiluminescence detection with high-throughput biochip technology using an integrated photoelectric sensor to read all signal points simultaneously.

An integrated biochemistry testing platform for clinical laboratory diagnostics. The system encompasses multiple biochemical assays approved for clinical use in patient sample analysis.

A compact, intelligent chemiluminescence detection platform designed for accurate diagnostic testing. The system features 20+10 independent detection channels that can perform parallel testing, delivering results within 15 minutes with low maintenance costs and extended reagent shelf life. It utilizes acridinium ester chemiluminescence technology with direct marker participation in the luminescence reaction, achieving high sensitivity and stability with coefficient of variation (CV) ≤3%, combining the precision of chemiluminescence with the convenience of point-of-care testing.

CLIA platform providing results in 30-60 minutes with sandwich and competitive immunoassay formats. Features very high sensitivity at pg/mL range with wide dynamic range of 3-5 logs and compatibility with major analyzers.

A chemiluminescence-based immunoassay system for laboratory diagnostics. It utilizes chemiluminescence technology to detect and measure specific analytes in patient samples for various clinical applications.

Chemiluminescence reagents for in vitro diagnostic immunoassays, enabling quantitative detection of biomarkers in clinical samples. Designed for precision diagnostics across oncology, infectious disease, and chronic disease screening applications. Compatible with automated and manual chemiluminescence analyzers for high-throughput laboratory testing.

High-sensitivity diagnostic reagents utilizing chemiluminescence technology for CLIA diagnostics, providing conclusive results in modern laboratory settings.

An automated analyzer for point-of-care testing (POCT) that performs chemiluminescence immunoassays. The device is designed for immunological testing applications and is part of the company's in vitro diagnostic automation product portfolio.

Chemiluminescent detection reagents used in conjunction with automated immunoassay analyzers for diagnostic testing. These reagents enable the detection and quantification of various biomarkers and analytes in clinical laboratory applications.